Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

A new weight loss drug target could lower appetite and increase energy expenditure without causing nausea as a side effect.

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

The type 2 diabetes medication Ozempic has been hugely popular when ... metformin can contribute to modest weight reduction ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...